Home › Therapeutic areas › Oncology › Brain Metastases
Brain Metastases (3 companies)
Companies with an active program in Brain Metastases.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| EIKN | Eikon Therapeutics | Oncology | 1 | Phase 2 | $320M | 13 |
| KZIA | Kazia Therapeutics | NeurologyOncology Rare | 1 | Phase 2 | $82.0M | 13 |
| TLX | Telix Pharmaceuticals | Oncology | 1 | Approved | $3.27B | 25 |
No companies match.